Lamivudine, Dolutegravir — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

1 Recruiting

2 Completed trials

4 Sponsors

6 Countries

Phase III

Phase III: 3

Sponsors using this IMP

3 total

MODULO Recruiting

2024-515793-27-01 Phase III 1 country ANRS Maladies Infectieuses Emergentes; Centre De Recherches Et D'Etudes Sur La P…
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND-… Ended

2024-514047-28-00 Phase III 4 countries Gilead Sciences Inc.
Early DOlutegravir/LAmivudine Switching after virological suppression (EDOLAS Study) Ended

2024-518909-18-00 Phase III 1 country Societa Italiana Di Malattie Infettive E Tropicali SIMIT

Showing 1–3 of 3 trials